Cargando…

Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden

Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Ying, Bai, Xiangning, Zhang, Ji, Jernberg, Cecilia, Chromek, Milan, Hansson, Sverker, Frykman, Anne, Yang, Xi, Xiong, Yanwen, Wan, Chengsong, Matussek, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733975/
https://www.ncbi.nlm.nih.gov/pubmed/33179570
http://dx.doi.org/10.1080/22221751.2020.1850182
_version_ 1783622373865422848
author Hua, Ying
Bai, Xiangning
Zhang, Ji
Jernberg, Cecilia
Chromek, Milan
Hansson, Sverker
Frykman, Anne
Yang, Xi
Xiong, Yanwen
Wan, Chengsong
Matussek, Andreas
author_facet Hua, Ying
Bai, Xiangning
Zhang, Ji
Jernberg, Cecilia
Chromek, Milan
Hansson, Sverker
Frykman, Anne
Yang, Xi
Xiong, Yanwen
Wan, Chengsong
Matussek, Andreas
author_sort Hua, Ying
collection PubMed
description Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the prevalence and genetic diversity of eae among clinical STEC isolates from patients with diarrhea, BD, HUS as well as from asymptomatic STEC-positive individuals in Sweden with whole-genome sequencing. We found that 173 out of 239 (72.4%) of clinical STEC strains were eae positive. Six eae subtypes (ϵ1, γ1, β3, θ, ζ and ρ) were identified eae and its subtype γ1 were significantly overrepresented in O157:H7 strains isolated from BD and HUS patients. ϵ1 was associated with O121:H19 and O103:H2 strains, and β3 to O26:H11 strains. The combination of eae subtype γ1 and stx subtype (stx(2) or stx(1)+stx(2)) is more likely to cause severe disease, suggesting the possibility of using eae genotypes in risk assessment of STEC infection. In summary, this study demonstrated a high prevalence of eae in clinical STEC strains and considerable genetic diversity of eae in STEC strains in Sweden from 1994 through 2018, and revealed association between eae subtypes and disease severity.
format Online
Article
Text
id pubmed-7733975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-77339752020-12-18 Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden Hua, Ying Bai, Xiangning Zhang, Ji Jernberg, Cecilia Chromek, Milan Hansson, Sverker Frykman, Anne Yang, Xi Xiong, Yanwen Wan, Chengsong Matussek, Andreas Emerg Microbes Infect Research Article Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the prevalence and genetic diversity of eae among clinical STEC isolates from patients with diarrhea, BD, HUS as well as from asymptomatic STEC-positive individuals in Sweden with whole-genome sequencing. We found that 173 out of 239 (72.4%) of clinical STEC strains were eae positive. Six eae subtypes (ϵ1, γ1, β3, θ, ζ and ρ) were identified eae and its subtype γ1 were significantly overrepresented in O157:H7 strains isolated from BD and HUS patients. ϵ1 was associated with O121:H19 and O103:H2 strains, and β3 to O26:H11 strains. The combination of eae subtype γ1 and stx subtype (stx(2) or stx(1)+stx(2)) is more likely to cause severe disease, suggesting the possibility of using eae genotypes in risk assessment of STEC infection. In summary, this study demonstrated a high prevalence of eae in clinical STEC strains and considerable genetic diversity of eae in STEC strains in Sweden from 1994 through 2018, and revealed association between eae subtypes and disease severity. Taylor & Francis 2020-12-10 /pmc/articles/PMC7733975/ /pubmed/33179570 http://dx.doi.org/10.1080/22221751.2020.1850182 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hua, Ying
Bai, Xiangning
Zhang, Ji
Jernberg, Cecilia
Chromek, Milan
Hansson, Sverker
Frykman, Anne
Yang, Xi
Xiong, Yanwen
Wan, Chengsong
Matussek, Andreas
Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
title Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
title_full Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
title_fullStr Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
title_full_unstemmed Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
title_short Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
title_sort molecular characteristics of eae-positive clinical shiga toxin-producing escherichia coli in sweden
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733975/
https://www.ncbi.nlm.nih.gov/pubmed/33179570
http://dx.doi.org/10.1080/22221751.2020.1850182
work_keys_str_mv AT huaying molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT baixiangning molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT zhangji molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT jernbergcecilia molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT chromekmilan molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT hanssonsverker molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT frykmananne molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT yangxi molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT xiongyanwen molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT wanchengsong molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden
AT matussekandreas molecularcharacteristicsofeaepositiveclinicalshigatoxinproducingescherichiacoliinsweden